Hello nature readers. Would you like to receive this science briefing free in your inbox every day? Sign up here.
Studies in mice suggest that psilocybin, a psychoactive compound in magic mushrooms, could help prevent chemotherapy-induced neuropathy.
Credit: Victor de Schwanberg/SPL
Psilocybin may protect against chemotherapy-related nerve damage, according to a study in mice. The psychoactive compound appeared to prevent neuropathy, a debilitating side effect associated with some platinum-based chemotherapy drugs. Up to 60% of people receiving these treatments may develop neuropathy, which can cause persistent burning, pain or tingling in the hands and feet.
Moran Amit, an oncologist and study co-author, said that two doses of psilocybin given before chemotherapy completely prevented the adverse effects in mice. The findings could encourage further research into the use of psychedelic compounds beyond mental-health conditions such as depression. However, clinical studies in humans are needed to determine whether the treatment is safe and effective.
Nature | 5 minute read
Reference: Science paper
In vivo CAR-T cell therapy has eased autoimmune disease symptoms in 16 people, researchers report. The experimental treatment uses a modified virus to deliver genetic instructions directly to participants’ T cells. The engineered cells then produce chimeric antigen receptors, or CARs, that target antibodies made by immune cells attacking healthy tissues.
The results provide an early proof of concept for in vivo CAR-T therapy. Unlike conventional CAR-T treatments, which require cells to be removed from the body and modified in a laboratory, the new approach could be faster and less expensive to manufacture, said David Simon, a clinician and researcher. Larger studies will be needed to assess its long-term safety and effectiveness.
Nature | 5 minute read
Reference: New England Journal of Medicine paper
An experimental drug called daraxone lasib (Lasonc) could offer a new treatment option for lung cancer, according to results from a small clinical trial. The findings were announced one week after the U.S. Food and Drug Administration approved a drug for advanced pancreatic cancer.
A larger randomized study is now underway. It will compare daraxone lasib with standard chemotherapy in people with lung cancer. The results could help determine whether the FDA approves the drug for lung-cancer treatment.
Nature | 5 minute read
Reference: New England Journal of Medicine paper
Features and impressions
In the latest short story from the nature Futures series, two rebels become lost in a metropolis generated by artificial intelligence.
Nature | 6 minute read
In The Second Arrow of Time, mineralogist Robert Hazen and planetary scientist Michael Wong argue that the natural world’s transition from chaos to complex order may have been inevitable. The authors propose a new physical law that challenges the traditional interpretation of the second law of thermodynamics, which states that disorder generally increases.
“This book is fascinatingly written and very thought-provoking,” geologist Graham Shields wrote in a review. Although Shields argues that the authors’ case is “not solid,” he says the proposal is likely to generate debate among scientists and philosophers.
Nature | 6 minute read
DNA damage may contribute to several hallmarks of aging, including chronic inflammation, metabolic changes and problems with protein folding. At the same time, the human body has highly efficient DNA-repair systems that correct countless forms of damage every day, including damage caused by ultraviolet light.
Scientists are investigating whether improving DNA repair could slow biological aging and help people remain healthy for longer. Research into long-lived species such as bowhead whales (Balaena mysticetus) and naked mole-rats (Heterocephalus glaber), along with genetic studies of centenarians, is providing new insights into this potential approach.
Nature Podcast | Listen for 18 minutes
Subscribe to the Nature Podcast on Apple Podcasts, Spotify, YouTube Music or the RSS feed.
Source: www.nature.com



